Related Experiment Video
Updated: Jan 26, 2026

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay
Published on: April 14, 2014
Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer
Victoria H Cruz1, Emily N Arner1, Wenting Du1
1Division of Surgical Oncology, Department of Surgery, and the Hamon Center for Therapeutic Oncology Research.
Abstract:
Pancreatic ductal adenocarcinoma (PDA) is characterized by an activating mutation in KRAS. Direct inhibition of KRAS through pharmacological means remains a challenge; however, targeting key KRAS effectors has therapeutic potential. We investigated the contribution of TANK-binding kinase 1 (TBK1), a critical downstream effector of mutant active KRAS, to PDA progression. We report that TBK1 supports the growth and metastasis of KRAS-mutant PDA by driving an epithelial plasticity program in tumor cells that enhances invasive and metastatic capacity. Further, we identify that the receptor tyrosine kinase Axl induces TBK1 activity in a Ras-RalB-dependent manner. These findings demonstrate that TBK1 is central to an Axl-driven epithelial-mesenchymal transition in KRAS-mutant PDA and suggest that interruption of the Axl-TBK1 signaling cascade above or below KRAS has potential therapeutic efficacy in this recalcitrant disease.
Insights
Targeting TANK-binding kinase 1 (TBK1) may treat pancreatic ductal adenocarcinoma (PDA). TBK1 drives tumor growth and metastasis in KRAS-mutant PDA by promoting epithelial plasticity and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDA) is driven by KRAS mutations.
- Directly inhibiting KRAS is challenging, necessitating alternative therapeutic strategies.
- Identifying key KRAS effectors is crucial for developing novel PDA treatments.
Purpose of the Study:
- To investigate the role of TANK-binding kinase 1 (TBK1) in KRAS-mutant PDA progression.
- To elucidate the mechanisms by which TBK1 contributes to tumor growth and metastasis.
- To explore the relationship between Axl receptor tyrosine kinase and TBK1 activity in PDA.
Main Methods:
- Investigated the contribution of TBK1 to PDA progression in KRAS-mutant models.
- Analyzed TBK1's role in driving epithelial plasticity, invasion, and metastasis.
- Examined the induction of TBK1 activity by Axl receptor tyrosine kinase via Ras-RalB signaling.
Main Results:
- TBK1 supports the growth and metastasis of KRAS-mutant PDA.
- TBK1 drives an epithelial plasticity program that enhances tumor cell invasiveness.
- Axl receptor tyrosine kinase induces TBK1 activity in a Ras-RalB-dependent manner.
Conclusions:
- TBK1 is a critical downstream effector of mutant KRAS in PDA.
- TBK1 is central to an Axl-driven epithelial-mesenchymal transition in KRAS-mutant PDA.
- Targeting the Axl-TBK1 signaling cascade offers potential therapeutic strategies for PDA.
Related Concept Videos
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Plasticity
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Plastic Behavior
Plastic Deformations
Plastic Deformations

